Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Milestone Pharmaceuticals Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −3 vs. Q4 2024
- Shares held
- 11.8M
- −12.7M (−51.8%) vs. Q4 2024
- Total value
- $9.46M
- −$48.5M (−83.7%) vs. Q4 2024
- New holders
- 14
- 6 more added
- Sold out
- 17
- 11 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 2 | $2 | 0.00% | −327−99.4% | Reduced |
| SBI Securities Co., Ltd. | 4 | $3 | 0.00% | +4 | New |
| US Bancorp | 3,200 | $2.56K | 0.00% | +3,200 | New |
| JPMorgan Chase & Co | 3,266 | $2.61K | 0.00% | +2,366+262.9% | Added |
| Royal Bank of Canada | 10,000 | $8.00K | 0.00% | +10,000 | New |
| Ancora Advisors, LLC | 10,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Integrated Wealth Concepts LLC | 10,000 | $8.00K | 0.00% | +10,000 | New |
| Clear Creek Financial Management, LLC | 10,500 | $8.40K | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 11,000 | $9.68K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 13,000 | $10.4K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 13,410 | $10.7K | 0.00% | −770−5.4% | Reduced |
| Beta Wealth Group, Inc. | 14,127 | $11.3K | 0.00% | 00.0% | Unchanged |
| Journey Strategic Wealth LLC | 15,000 | $12.0K | 0.00% | +15,000 | New |
| State Street Corp | 18,537 | $14.8K | 0.00% | −580−3.0% | Reduced |
| National Bank of Canada | 18,700 | $15.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 19,872 | $15.9K | 0.00% | 00.0% | Unchanged |
| Valeo Financial Advisors, LLC | 20,000 | $16.0K | 0.00% | 00.0% | Unchanged |
| Scientech Research LLC | 22,918 | $18.3K | 0.00% | +22,918 | New |
| Safeguard Investment Advisory Group, LLC | 25,044 | $20.0K | 0.01% | +25,044 | New |
| BNP Paribas Arbitrage, SA | 26,023 | $20.8K | 0.00% | −5,110−16.4% | Reduced |
| Raymond James Financial Inc | 33,235 | $26.6K | 0.00% | +33,235 | New |
| Bank of America Corp | 39,396 | $31.5K | 0.00% | +39,396 | New |
| Dimensional Fund Advisors LP | 39,450 | $31.7K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 40,636 | $32.0K | 0.00% | +35,994+775.4% | Added |
| XTX Topco Ltd | 52,004 | $41.6K | 0.00% | +17,950+52.7% | Added |
| Northern Trust Corp | 53,001 | $42.4K | 0.00% | −5,107−8.8% | Reduced |
| Susquehanna International Group, LLP | 62,060 | $49.7K | 0.00% | +28,968+87.5% | Added |
| Two Sigma Advisers, LP | 76,000 | $60.8K | 0.00% | +76,000 | New |
| Walleye Capital LLC | 91,920 | $73.5K | 0.00% | +91,920 | New |
| UBS Group AG | 111,523 | $89.2K | 0.00% | +22,017+24.6% | Added |
| LPL Financial LLC | 111,540 | $89.2K | 0.00% | +111,540 | New |
| Group One Trading, L.P. | 138,360 | $110.7K | 0.00% | +85,723+162.9% | Added |
| Stonepine Capital Management, LLC | 250,000 | $200.0K | 0.23% | −250,000−50.0% | Reduced |
| Millennium Management LLC | 322,082 | $257.7K | 0.00% | −2,381,177−88.1% | Reduced |
| Bleichroeder LP | 500,000 | $400.1K | 0.11% | −826,085−62.3% | Reduced |
| Lion Point Capital, LP | 548,806 | $439.1K | 2.80% | −477,000−46.5% | Reduced |
| Toronto Dominion Bank | 750,000 | $600.1K | 0.00% | 00.0% | Unchanged |
| Simplify Asset Management Inc. | 850,000 | $680.1K | 0.03% | +850,000 | New |
| Morgan Stanley | 968,525 | $774.9K | 0.00% | −320,616−24.9% | Reduced |
| BML Capital Management, LLC | 1,136,091 | $909.0K | 0.74% | 00.0% | Unchanged |
| Alta Fundamental Advisers LLC | 1,427,479 | $1.14M | 0.74% | −1,231,110−46.3% | Reduced |
| Propel Bio Management, LLC | 1,451,557 | $1.16M | 1.35% | +1,451,557 | New |
| RTW Investments, LP | 2,506,102 | $2.01M | 0.03% | 00.0% | Unchanged |
| BlackRock, Inc. | 0 | $0 | 0.00% | −4,050,686−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −2,000,000−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −1,445,264−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −942,407−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −608,202−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −466,030−100.0% | Sold out |
| Boxer Capital Management, LLC | 0 | $0 | 0.00% | −309,007−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −71,955−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −63,742−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −56,751−100.0% | Sold out |
| Atria Investments LLC | 0 | $0 | 0.00% | −38,666−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −30,938−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −30,790−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −24,731−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,957−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −6,934−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Oliver Lagore Vanvalin Investment Group | – | – | – | – | Not filed |